Following the news earlier this week that the EU had discovered traces of banned antibiotics in some Thai food imports, shares in Thai food exporters have slumped.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more


By the mid-session break today [Friday], shares in Charoen Pokphand Foods (CPF), Thailand’s biggest chicken exporter, were down 1.5% to Bt6.4 (US$0.15), while GFPT had slipped 6.6% to Bt42.75.


An antibiotic drug called nitrofuran was found in samples of warm-water prawns and shrimp imported into the EU from Thailand and a number of other South Asian countries including Vietnam, which yesterday denied the problem. It was also found in poultry imported from Thailand.


The European Commission said this week it would start testing all Thai poultry as well as shrimp from Vietnam, Thailand and Myanmar for banned drugs. If more traces of nitrofuran are discovered, the EU may decide to ban shrimp and chicken from the relevant countries, which would hit processors hard. GFPT generates 50% of its revenues from exports to the EU.


CPF would not be so hard hit as shrimp and chicken exports to the EU account for just 9% of its total food exports.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - Nominations Closed

Nominations are now closed for the Just Food Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Winning five categories in the 2025 Just Food Excellence Awards, Centric Software is setting the pace for digital transformation in food and FMCG. Explore how its integrated PLM and PXM suite delivers faster launches, smarter compliance and data-driven growth for complex, multi-channel product portfolios.

Discover the Impact